Article List

WPRIM Management System> DCMS> Annals of the Academy of Medicine, Singapore> 2012> 41> 12

Volume: 41 Issue: 12

1. Into the shadow: a reflection on the stigma of human immunodeficiency virus (HIV) in Singapore.	Page:625—627
2. Progressive Multifocal Leukoencephalopathy with Immune Reconstitution Inflammatory Syndrome (PML-IRIS): two case reports of successful treatment with mefloquine and a review of the literature.	Page:620—624
3. Acute retroviral syndrome mimics dengue in Singapore.	Page:617—619
4. Phasing out the use of stavudine in Singapore: how are we doing in compliance to World Health Organization (WHO) recommendations?	Page:615—616
5. The role of lesbian, gay, bisexual, transgender and questioning-focused psychosocial approaches as part of human immunodeficiency virus (HIV) prevention efforts in Singapore.	Page:610—614
6. Human immunodeficiency virus (HIV) prevention education in Singapore: challenges for the future.	Page:602—609
7. Biomedical strategies for human immunodeficiency virus (HIV) prevention? A new paradigm.	Page:595—601
8. Human immunodeficiency virus (HIV) in pregnancy: a review of the guidelines for preventing mother-to-child transmission in Malaysia.	Page:587—594
9. Presentation and outcome amongst older Singaporeans living with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): does age alone drive excess mortality?	Page:581—586
10. Older age at initial presentation to human immunodeficiency virus (HIV) care and treatment at the Communicable Disease Centre (CDC) in Singapore, 2006 to 2011.	Page:577—580
11. Causes of death in hospitalised HIV-infected patients at a National Referral Centre in Singapore: a retrospective review from 2008 to 2010.	Page:571—576
12. Causes of death and factors associated with early death among human immunodeficiency virus (HIV)-infected persons in Singapore: pre-highly active antiretroviral therapy (HAART) and Peri-HAART.	Page:563—570
13. Unexpected drug-drug interactions in human immunodeficiency virus (HIV) therapy: induction of UGT1A1 and bile efflux transporters by Efavirenz.	Page:559—562
14. Clinical evaluation of an in-house human immunodeficiency virus (HIV) genotyping assay for the detection of drug resistance mutations in HIV-1 infected patients in Singapore.	Page:553—558
15. The human immunodeficiency virus (HIV) epidemic in Singapore - where are we now, and can we "get to zero"?	Page:551—552